Age-related macular degeneration
Pfizer/Astellas share positive overall survival results for Xtandi in prostate cancer
Around 55,100 cases of prostate cancer are diagnosed in the UK every year
Pfizer/Astellas share positive phase 3 results for Padcev in bladder cancer
Approximately 614,000 people are diagnosed with bladder cancer globally every year
Astellas’ Vyloy combination approved by MHRA as first-line gastric cancer treatment
Approximately 6,600 new cases of the disease are diagnosed in the UK every year
Astellas signs $962m rare eye disease deal with 4D Molecular Therapeutics
The company will gain the rights to use 4DMT’s gene therapy vector for at least one target
Astellas to acquire Iveric Bio for approximately $5.9bn
The deal includes the US drugmaker’s lead candidate for geographic atrophy
Positive results for Astellas’ zolbetuximab in gastric cancer published in The Lancet
Over one million new cases of gastric cancer were diagnosed globally in 2020
Biogen takes on Lucentis, Eylea biosimilars from Samsung joint venture
Will pay $100m upfont and pledges $210m in milestone payments
